All practice questions

8270 questions

Question 3261Question →

A 68-year-old woman is brought to the emergency department by her son due to progressive behavioral changes over the past 5 weeks. She has developed profound sadness, anhedonia, and terminal insomnia, typically waking at 3:00 AM and unable to return to sleep. For the past week, she has refused all food and water, repeatedly stating, "My stomach has turned to dust, it cannot process anything." She has lost 6 kg (13.2 lbs) during this period. Her medical history is significant for Parkinson disease, for which she has been taking carbidopa-levodopa and selegiline for three years.

Vital signs show a blood pressure of 96/60 mmHg and a heart rate of 112/min. Physical examination reveals severely dry mucous membranes and decreased skin turgor.

Laboratory studies show:
TestResultReference Range
Sodium152 mEq/L136-145 mEq/L
Blood urea nitrogen45 mg/dL7-18 mg/dL
Creatinine1.6 mg/dL0.6-1.2 mg/dL
Thyroid-stimulating hormone (TSH)0.1 µU/mL0.5-5.0 µU/mL
Free thyroxine (T4)0.5 ng/dL0.9-1.7 ng/dL

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Admit for intravenous hydration and electroconvulsive therapy (ECT)

Answer

Admit for intravenous hydration and electroconvulsive therapy (ECT)
This patient presents with a severe episode of Major Depressive Disorder (MDD) with psychotic features (Cotard delusion, i.e., the belief that her stomach has turned to dust) and melancholic features (terminal insomnia, profound weight loss). Her absolute refusal to eat or drink has resulted in severe dehydration, hypernatremia, and prerenal azotemia, representing a life-threatening psychiatric emergency. In cases of psychotic depression complicated by active starvation, severe suicidality, or when standard medications are contraindicated, Electroconvulsive therapy (ECT) is the gold-standard treatment due to its rapid onset and high efficacy. Intravenous hydration must be provided concurrently to stabilize her medical condition.

Step-by-Step Solution

1
Identify the primary psychiatric syndrome based on the clinical presentation.
The patient has 5 weeks of melancholic depression and recent onset of somatic delusions, leading to a diagnosis of Major Depressive Disorder (MDD) with psychotic features.
Accurate diagnosis is required to guide psychopharmacologic or procedural interventions.
2
Assess clinical acuity and immediate life threats.
The patient's delusion has led to absolute food and fluid refusal, resulting in severe dehydration (hypernatremia) and acute kidney injury (prerenal azotemia).
Conditions involving active starvation or imminent danger to self necessitate rapid, aggressive intervention.
3
Evaluate the patient's medication list for potential pharmacological constraints.
The patient takes selegiline, a monoamine oxidase B (MAO-B) inhibitor. Initiating standard first-line therapies for psychotic depression (like SSRIs or SNRIs) is strictly contraindicated.
Combining serotonergic agents with an MAOI carries a high risk of precipitating fatal serotonin syndrome.
4
Determine the optimal intervention balancing efficacy, speed, and safety.
Electroconvulsive therapy (ECT) combined with supportive medical care (IV hydration) is the safest and most effective choice.
ECT provides rapid symptom relief for life-threatening psychotic depression and bypasses the dangerous drug-drug interactions posed by her Parkinson disease medications.

Key Concept

Management of severe major depressive disorder with psychotic features and life-threatening food refusal
Question 3262Question →

A 32-year-old man comes to the primary care clinic seeking advice on weight management. He reports a long history of fluctuating weight and significant distress regarding his body size. His body mass index is 35 kg/m². During the interview, he describes frequent episodes where he consumes unusually large amounts of food, such as eating an entire family-sized pizza and a large carton of ice cream in less than an hour. During these times, he feels a complete loss of control over his eating. These episodes occur at least twice a week and are followed by intense feelings of guilt and self-disgust. He explicitly denies inducing vomiting, using laxatives, fasting, or engaging in excessive exercise after these eating episodes. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Binge-eating disorder

Answer

Binge-eating disorder
The correct answer accurately identifies binge-eating disorder. This diagnosis is characterized by recurrent episodes of binge eating (eating an amount of food that is definitely larger than what most people would eat in a similar period, with a sense of lack of control) that occur at least once a week for 3 months. Crucially, these episodes are accompanied by marked distress (guilt, self-disgust) and are not followed by the recurrent use of inappropriate compensatory behaviors such as purging, fasting, or excessive exercise.

Step-by-Step Solution

1
Analyze the patient's eating behavior and psychological response.
The patient has episodes of eating unusually large amounts of food in a short period, accompanied by a loss of control, guilt, and self-disgust.
Identifying the core pattern of eating helps narrow down the psychiatric differential diagnosis of eating disorders.
2
Assess for the presence of compensatory behaviors.
The patient explicitly denies vomiting, laxative use, fasting, or excessive exercise.
The presence or absence of compensatory behaviors is the primary way to differentiate bulimia nervosa from binge-eating disorder.
3
Evaluate the patient's body mass index (BMI).
The patient's BMI is 35 kg/m², indicating obesity rather than a significantly low body weight.
A BMI above the normal or underweight range rules out anorexia nervosa.

Key Concept

Binge-eating disorder is diagnosed when a patient has recurrent episodes of binge eating associated with a lack of control and severe distress, but notably lacks the inappropriate compensatory behaviors seen in bulimia nervosa.
Estimated Time:1m 0s
Question 3263Question →

Review the following psychiatric clinical scenarios and correlate each presentation with the most accurate DSM-5 diagnostic classification.

Click a left item, then click its matching right item

Items

A 34-year-old woman experiences auditory hallucinations and persecutory delusions for 3 weeks following the sudden death of her spouse, after which she completely returns to her previous baseline.
A 25-year-old man exhibits disorganized speech, flattened affect, and delusions of being continuously monitored by the government for the past 8 months, accompanied by a severe decline in occupational functioning.
A 41-year-old man functions well at his accounting job but has firmly believed for the past 6 months that his neighbor is secretly poisoning his water supply. He exhibits no hallucinations or disorganized behavior.
A 29-year-old woman presents with a 4-month history of prominent auditory hallucinations and severe social withdrawal, with no history of major depressive or manic episodes.

Matches

Show answer & explanation

Answer

The correct correlations rely heavily on the timeline of symptoms: <1 month is brief psychotic disorder, 1-6 months is schizophreniform disorder, >6 months is schizophrenia, and isolated delusions without other psychotic symptoms point to delusional disorder.
Each diagnosis is accurately determined by strictly adhering to the DSM-5 duration criteria and specific symptom profiles. Brief psychotic disorder requires symptoms lasting less than 1 month, schizophreniform disorder lasts 1 to 6 months, schizophrenia requires at least 6 months of symptoms, and delusional disorder is characterized by isolated delusions for >1 month without the global functional decline or other prominent psychotic symptoms seen in schizophrenia.

Step-by-Step Solution

1
Identify the primary psychotic symptoms and level of functional impairment in each scenario.
Three patients have multiple psychotic symptoms (hallucinations, disorganized speech), while one patient only has an isolated delusion.
Distinguishing the breadth of psychotic symptoms separates delusional disorder from the schizophrenia spectrum.
2
Evaluate the exact duration of symptoms for the remaining three patients on the schizophrenia spectrum.
The durations are 3 weeks, 4 months, and 8 months.
Duration is the primary diagnostic differentiator for these primary psychotic disorders.
3
Correlate the observed durations with DSM-5 criteria.
3 weeks (<1 month) = Brief psychotic disorder. 4 months (1-6 months) = Schizophreniform disorder. 8 months (>6 months) = Schizophrenia.
This establishes the definitive diagnoses based on standard psychiatric criteria.

Key Concept

Differentiation of primary psychotic disorders based on symptom duration and specific symptom profiles.
Question 3264Question →

A 28-year-old woman, 3 months postpartum, is brought to the clinic by her husband for a psychiatric evaluation. She has been exclusively formula-feeding her infant. For the past 4 weeks, she has experienced profound sadness, frequent crying spells, excessive sleepiness, and an inability to care for her baby. She states, "I am a terrible mother and my baby deserves better." Three weeks ago, her obstetrician prescribed sertraline, but she discontinued it after 5 days because she "felt it wasn't working fast enough." Her husband notes that 4 years ago, she had a 2-week period where she slept only 2 hours a night, spoke rapidly, and claimed she was chosen by God to lead a new religion; this episode required a brief psychiatric hospitalization. Her temperature is 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure is 110/70 mm Hg110/70 \text{ mm Hg}, and pulse is 78/min78/\text{min}. Physical examination is unremarkable. Laboratory studies show a thyroid-stimulating hormone (TSH) level of 1.5 μU/mL1.5 \ \mu\text{U/mL} (normal: 0.5−5.00.5-5.0). She is currently taking no medications. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate lurasidone therapy

Answer

Initiate lurasidone therapy
The patient is currently experiencing a major depressive episode, but her clear history of a 2-week manic episode with psychotic features (delusions of being chosen by God) requiring hospitalization establishes a definitive diagnosis of Bipolar I disorder. Therefore, her current presentation is bipolar depression. First-line pharmacologic treatment for acute bipolar depression includes specific atypical antipsychotics such as lurasidone, quetiapine, or cariprazine. These medications effectively target depressive symptoms in bipolar disorder without the high risk of precipitating a manic episode.

Step-by-Step Solution

1
Evaluate the current clinical presentation and psychiatric history.
The patient meets criteria for a major depressive episode, but her history of a 2-week period with decreased need for sleep, rapid speech, grandiosity, and psychotic features confirms an underlying diagnosis of Bipolar I disorder.
Establishing the correct diagnosis (Bipolar I disorder, current episode depressed) is essential to distinguish it from unipolar major depressive disorder before selecting pharmacotherapy.
2
Analyze prior medication trials and assess risks.
The patient previously received sertraline (an SSRI), which she prematurely discontinued. Restarting an SSRI as monotherapy is contraindicated in bipolar disorder due to the high risk of iatrogenic manic switching.
Recognizing the danger of antidepressant monotherapy in bipolar patients prevents severe adverse outcomes like acute mania.
3
Select the most appropriate pharmacotherapy for bipolar depression.
Lurasidone is selected.
Atypical antipsychotics (such as lurasidone, quetiapine, or cariprazine) are FDA-approved first-line treatments for acute bipolar depression.

Key Concept

Patients presenting with a major depressive episode must be carefully screened for a history of mania or hypomania; if a bipolar disorder diagnosis is established, antidepressant monotherapy should be avoided and first-line bipolar depression agents (e.g., lurasidone, quetiapine) should be initiated.
Estimated Time:1m 30s
Question 3265Question →

Match each patient's clinical presentation with the most appropriate next step in management or pharmacotherapy.

Click a left item, then click its matching right item

Items

A 31-year-old woman with 4 weeks of severe depression and anhedonia; history reveals a past 6-day episode of decreased need for sleep, grandiosity, and impulsive spending.
A 74-year-old man with 1 month of profound depression, delusions of poverty, and refusal to eat or drink resulting in severe dehydration and acute kidney injury.
A 45-year-old woman with major depressive disorder, previously well-controlled on paroxetine, who was recently diagnosed with breast cancer and initiated on adjuvant tamoxifen therapy.
A 60-year-old man developing major depressive disorder 4 weeks after a myocardial infarction; he requires pharmacotherapy but has a left ventricular ejection fraction of 35%.
A 21-year-old man presenting with 2 weeks of depressed mood, profound fatigue, hypersomnia, and increased appetite, which began 4 days after abruptly discontinuing his prescribed high-dose amphetamines.

Matches

Show answer & explanation

Answer

The clinical scenarios map to specific management branch points: bipolar depression (quetiapine/lurasidone), life-threatening psychotic depression (ECT), CYP2D6 drug interactions (switch from paroxetine), post-myocardial infarction depression (sertraline), and amphetamine withdrawal (supportive care).
Each clinical vignette tests a critical, high-yield branch point in the management of depressive presentations. The 31-year-old patient has unrecognized bipolar II disorder, requiring bipolar-specific agents (quetiapine/lurasidone) rather than SSRI monotherapy to avoid mood destabilization. The 74-year-old patient has severe psychotic depression with life-threatening starvation, making ECT the treatment of choice due to its rapid onset and high efficacy. The 45-year-old patient is taking tamoxifen, which requires CYP2D6 for activation; paroxetine is a strong CYP2D6 inhibitor and must be switched to an agent with minimal inhibition like venlafaxine. The 60-year-old patient requires depression treatment post-myocardial infarction, where sertraline is the evidence-based SSRI of choice due to excellent cardiovascular safety. The 21-year-old patient is experiencing amphetamine withdrawal, which mimics atypical depression but is a substance-induced, self-limiting condition that requires only supportive care.

Step-by-Step Solution

1
Evaluate the 31-year-old woman's history of a distinct 6-day episode of decreased sleep and grandiosity.
Diagnose bipolar II disorder, current episode depressed.
Screening for past hypomania/mania is critical before treating depression to avoid precipitating a manic switch with antidepressant monotherapy.
2
Assess the 74-year-old man's psychotic features combined with his refusal to eat.
Identify a life-threatening psychiatric emergency.
Severe physical compromise (starvation, acute kidney injury) in the context of psychotic depression requires the most rapid and effective intervention, which is ECT.
3
Analyze the drug-drug interaction between paroxetine and tamoxifen in the 45-year-old woman.
Identify paroxetine as a strong CYP2D6 inhibitor that drastically reduces tamoxifen's therapeutic efficacy.
Tamoxifen is a prodrug requiring CYP2D6 for conversion to its active anti-estrogen metabolite (endoxifen); a non-inhibiting alternative antidepressant must be chosen.
4
Determine the safest antidepressant for the 60-year-old man post-myocardial infarction with a reduced ejection fraction.
Select sertraline as the optimal pharmacotherapy.
Sertraline has an extensively established cardiovascular safety profile in patients with recent ischemic heart disease, unlike tricyclics or citalopram (which prolongs QTc).
5
Differentiate the etiology of the 21-year-old man's depressive symptoms occurring strictly after discontinuation of amphetamines.
Diagnose amphetamine withdrawal rather than a primary major depressive episode with atypical features.
Amphetamine 'crash' presents with profound depression, hypersomnia, and hyperphagia, but the temporal link to discontinuation indicates a self-limiting toxidrome requiring only supportive care.

Key Concept

The precise management of depressive disorders requires careful differentiation of unipolar vs. bipolar illness, recognition of life-threatening emergencies requiring ECT, mitigation of critical drug interactions (e.g., CYP2D6), understanding of cardiovascular safety, and distinguishing primary depression from substance withdrawal.
Question 3266Question →

Match each of the following patient clinical vignettes with the most appropriate personality disorder diagnosis.

Click a left item, then click its matching right item

Items

A 28-year-old man with a history of childhood conduct disorder frequently lies to coworkers for financial gain, acts aggressively when confronted, and shows no remorse for exploiting his peers.
A 32-year-old woman declines a promotion to team lead because she is terrified her colleagues will criticize her performance, despite expressing a deep longing to have closer work friendships.
A 45-year-old executive demands to be evaluated only by the CEO, frequently takes credit for his subordinates' work, and becomes visibly enraged when he is not praised during meetings.
A 36-year-old accountant spends hours perfectly aligning his spreadsheets, insists that his team follow his exact rigid protocols, and consistently misses project deadlines due to his extreme perfectionism.

Matches

Show answer & explanation

Answer

The correct matches are Antisocial PD for the deceitful man, Avoidant PD for the anxious woman desiring connection, Narcissistic PD for the grandiose executive, and Obsessive-Compulsive PD for the rigid perfectionist.
Each personality disorder can be identified by its core pervasive pattern. Antisocial PD is marked by disregard for others' rights. Avoidant PD involves social inhibition and hypersensitivity to negative evaluation. Narcissistic PD requires grandiosity and need for admiration. Obsessive-Compulsive PD involves pervasive preoccupation with order, perfection, and control.

Step-by-Step Solution

1
Evaluate the 28-year-old man's presentation.
Antisocial Personality Disorder.
Deceitfulness, lack of remorse, and aggressive behavior align with Cluster B antisocial traits.
2
Evaluate the 32-year-old woman's presentation.
Avoidant Personality Disorder.
Avoidance of occupational activities due to fear of criticism while still desiring social contact is classic for this Cluster C disorder.
3
Evaluate the 45-year-old executive's presentation.
Narcissistic Personality Disorder.
Grandiosity, need for admiration, and interpersonal exploitation are characteristic of this Cluster B disorder.
4
Evaluate the 36-year-old accountant's presentation.
Obsessive-Compulsive Personality Disorder.
Preoccupation with orderliness, perfectionism causing inefficiency, and rigidity identify this Cluster C disorder.

Key Concept

Differentiating personality disorders based on core clinical features across Clusters B and C.
Question 3267Question →

A 17-year-old male is evaluated in the emergency department after experiencing a syncopal episode during cross-country track practice. He reports strictly limiting his food intake over the past 8 months to 'optimize his race times' and has subsequently lost 18 kg (40 lb). Temperature is 35.8°C (96.4°F), blood pressure is 80/50 mmHg, pulse is 38/min, and BMI is 13.5 kg/m². Physical examination reveals temporal wasting, lanugo on his back, and cold, cyanotic extremities. An electrocardiogram reveals marked sinus bradycardia with a prolonged QTc interval. Laboratory studies demonstrate significant hypokalemia, hypomagnesemia, and hypophosphatemia. Arrange the following interventions in the most appropriate chronological order for the comprehensive management of this patient, from the most immediate acute intervention to long-term follow-up.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence prioritizes immediate medical survival and hemodynamic stability, followed by metabolic correction, safe refeeding, psychotherapy, and finally, outpatient step-down care.
The correct sequence reflects the hierarchy of clinical urgency in severe anorexia nervosa. Immediate survival depends on recognizing the need for a medical (not psychiatric) inpatient level of care due to profound hemodynamic instability (bradycardia, hypotension, syncope). Once admitted and placed on telemetry, the most imminent threat to life is a fatal arrhythmia secondary to QTc prolongation and intracellular electrolyte depletion; therefore, intravenous repletion of potassium, magnesium, and phosphate is prioritized. Starvation is then addressed via a low-calorie, gradually advancing nutritional protocol to prevent refeeding syndrome. Only after the brain receives adequate nutrition and the patient achieves medical stability can psychotherapy (such as Family-Based Therapy, the gold standard for adolescents) be meaningfully implemented. Finally, the patient is transitioned to a step-down intensive outpatient program to ensure continued weight gain and prevent relapse.

Step-by-Step Solution

1
Assess hemodynamic and medical stability.
Patient is admitted to a medical inpatient unit with telemetry.
A BMI < 15 kg/m², severe bradycardia, hypotension, and QTc prolongation are absolute indications for medical hospitalization with continuous cardiac monitoring.
2
Correct life-threatening metabolic and electrolyte derangements.
Intravenous potassium, magnesium, and phosphate are administered.
Hypokalemia and hypophosphatemia, combined with a prolonged QTc, pose an imminent risk for torsades de pointes and must be addressed prior to or concurrently with feeding.
3
Reverse the starvation state safely.
A titrated, low-calorie enteral nutritional rehabilitation protocol is initiated.
Providing calories too rapidly in a severely malnourished state precipitates refeeding syndrome; thus, strictly controlled caloric advancement is required.
4
Address the underlying psychiatric pathology.
Family-based therapy (FBT) is commenced.
Psychotherapy is the cornerstone of long-term eating disorder treatment but is ineffective when a patient is acutely starving and cognitively impaired from malnutrition.
5
Coordinate long-term recovery and maintenance.
The patient is discharged to an intensive outpatient program.
Maintenance of weight restoration and prevention of relapse require continuous, structured psychiatric and nutritional support outside the hospital.

Key Concept

The management of severe anorexia nervosa requires a strict hierarchy of interventions: acute medical stabilization (inpatient telemetry), metabolic correction (electrolyte repletion), physiological restoration (titrated refeeding), and finally psychological rehabilitation (family-based therapy and outpatient step-down care).
Question 3268Question →

A 41-year-old man is brought to the emergency department by emergency medical services due to severe agitation and abdominal cramps. The patient states he was discharged earlier this morning from a residential rehabilitation facility after completing a 5-day medically supervised withdrawal for alcohol use disorder. His past medical history is significant for a 10-year history of severe opioid use disorder, for which he has been enrolled in a methadone maintenance program for the last 3 years with no recent illicit opioid use. At the time of his discharge from the alcohol rehabilitation facility today, he was prescribed a daily oral medication to reduce alcohol cravings. He took the first dose of this new medication 45 minutes ago and rapidly developed his current symptoms. He denies consuming any alcohol since entering the rehabilitation program. His temperature is 37.8°C (100.0°F), blood pressure is 156/94 mm Hg, pulse is 112/min, and respirations are 22/min. Physical examination reveals a restless, profusely diaphoretic man. He is yawning frequently and has prominent rhinorrhea. Pupils are dilated at 7 mm bilaterally and reactive to light. Neuromuscular examination reveals diffuse myalgias but no rigidity or clonus. Bowel sounds are hyperactive. The medication prescribed at discharge most likely exerts its primary effect at which of the following targets?

Show answer & explanation

Answer: Mu-opioid receptor

Answer

The correct answer is the Mu-opioid receptor, which is the target of naltrexone.
The correct answer is the Mu-opioid receptor. This patient is experiencing precipitated opioid withdrawal, as evidenced by the classic constellation of yawning, rhinorrhea, mydriasis, diaphoresis, abdominal cramps, and hyperactive bowel sounds. He was recently prescribed a medication to reduce alcohol cravings following detoxification. Naltrexone is a first-line pharmacotherapy for alcohol use disorder that acts as a competitive antagonist at the mu-opioid receptor. Because this patient is maintained on methadone (a full mu-opioid agonist), the introduction of naltrexone rapidly displaced methadone from the opioid receptors, immediately precipitating severe withdrawal. Naltrexone is absolutely contraindicated in patients receiving opioid therapy or those with active opioid dependence.

Step-by-Step Solution

1
Identify the clinical syndrome from the physical examination.
The patient presents with yawning, rhinorrhea, mydriasis, diaphoresis, myalgias, abdominal cramps, and hyperactive bowel sounds.
This specific constellation of symptoms is the classic toxidrome of acute opioid withdrawal.
2
Analyze the patient's medical history and current medications.
The patient is physically dependent on methadone (a full opioid agonist) and was just prescribed a new medication for alcohol craving reduction.
Determines the baseline pharmacological state and identifies the event that triggered the acute change.
3
Determine the identity and mechanism of the newly prescribed medication.
Naltrexone is a first-line treatment for alcohol cravings. Its mechanism is competitive antagonism at the mu-opioid receptor.
Naltrexone is strictly contraindicated in patients on opioid therapy because it immediately displaces opioid agonists from receptors.
4
Synthesize the findings to answer the question.
The patient was erroneously prescribed naltrexone, which targeted his mu-opioid receptors, precipitating acute withdrawal.
Directly answers the stem's inquiry regarding the primary target of the offending drug.

Key Concept

Administration of naltrexone, a mu-opioid receptor antagonist used for alcohol use disorder, is absolutely contraindicated in patients receiving opioid agonists (e.g., methadone) as it will precipitate severe, acute opioid withdrawal.
Question 3269Question →

A 36-year-old nulligravida seeks medical advice because she has noticed red-tinged fluid staining her bra over the past three weeks. The leakage occurs spontaneously and is limited to her right side. She denies any associated breast pain, skin changes, or recent trauma. Menarche occurred at age 12, and her menstrual cycles are regular. She takes no medications and has no family history of breast or ovarian malignancy. On physical examination, vital signs are within normal limits. Careful palpation reveals no discrete breast masses or axillary lymphadenopathy. Gentle pressure around the right areola elicits a few drops of frankly bloody discharge from a single duct. A urine pregnancy test is negative. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Diagnostic mammography and targeted ultrasound

Answer

Diagnostic mammography and targeted ultrasound
This patient's presentation of spontaneous, unilateral, bloody discharge from a single duct is highly suspicious for a structural breast lesion, most commonly a benign intraductal papilloma, but it also carries a significant risk of underlying malignancy (e.g., ductal carcinoma in situ). Because this is considered pathologic nipple discharge, it requires prompt and thorough diagnostic imaging. The initial diagnostic approach is dictated by the patient's age. For women aged 30 years and older, the most appropriate first step in management is a diagnostic mammogram and targeted ultrasound of the affected breast. The mammogram screens for suspicious microcalcifications, while the ultrasound evaluates the retroareolar ducts for masses or ductal dilatation.

Step-by-Step Solution

1
Analyze the patient's symptoms and physical exam findings.
The patient presents with spontaneous, unilateral, bloody discharge from a single duct without a palpable mass.
Characterizing the discharge helps differentiate between physiologic and pathologic etiologies.
2
Categorize the discharge based on clinical features.
The discharge is classified as pathologic.
Pathologic nipple discharge is defined as unilateral, spontaneous, bloody, serous, or clear discharge originating from a single duct. It carries a higher risk of underlying structural lesions, including intraductal papilloma or ductal carcinoma.
3
Determine the age-appropriate initial imaging workup for pathologic nipple discharge.
For a 36-year-old woman, the correct initial step is diagnostic mammography combined with a targeted ultrasound.
Current guidelines recommend that patients under 30 with pathologic discharge undergo targeted ultrasound first, while those 30 and older require both mammography and ultrasound to adequately evaluate for malignancy.

Key Concept

Age-based diagnostic algorithm for pathologic nipple discharge
Question 3270Question →

A 41-year-old male electrician is brought to the outpatient psychiatric clinic by his brother. The patient reports a 6-week history of overwhelming fatigue, anhedonia, and sleeping 12 to 14 hours daily. He has been unable to work and struggles to perform basic personal hygiene. Review of his psychiatric history reveals an episode three years ago during which he experienced a persistently elevated mood, believed he had discovered a groundbreaking theory of electricity, and stayed awake for 8 days straight working on erratic diagrams. That episode culminated in involuntary psychiatric hospitalization. He currently takes no medications, and his basic laboratory workup, including a thyroid panel, is unremarkable. Which of the following is the most appropriate pharmacotherapy for this patient's current presentation?

Show answer & explanation

Answer: Lithium carbonate

Answer

Lithium carbonate
This patient is presenting with a major depressive episode and has a clear history of a severe manic episode (grandiosity, decreased need for sleep, required hospitalization), establishing a diagnosis of bipolar I disorder. The most appropriate treatment for an acute depressive episode in bipolar I disorder includes agents with specific efficacy for bipolar depression, such as lithium, quetiapine, lurasidone, or cariprazine. Lithium carbonate is a classic first-line mood stabilizer that effectively treats both the manic and depressive phases of bipolar disorder and has the unique added benefit of reducing long-term suicide risk.

Step-by-Step Solution

1
Identify the patient's current clinical state.
The patient is experiencing a major depressive episode, characterized by 6 weeks of severe fatigue, hypersomnia, anhedonia, and functional impairment.
Accurate identification of the current mood phase is necessary to guide symptom-specific treatment.
2
Analyze the patient's past psychiatric history.
The patient has a history of a severe manic episode featuring grandiosity, decreased need for sleep, and functional impairment requiring hospitalization.
A history of even a single manic episode changes the diagnosis from major depressive disorder to bipolar I disorder, fundamentally altering the treatment algorithm.
3
Select the appropriate pharmacotherapy for acute bipolar depression.
Lithium carbonate is chosen over antidepressant monotherapy or atypical antipsychotics that only target mania.
Bipolar depression must be treated with agents proven effective for this specific phase (e.g., lithium, quetiapine, lurasidone, cariprazine) while strictly avoiding antidepressant monotherapy to prevent a manic switch.

Key Concept

The treatment of acute bipolar depression requires specific mood stabilizers or select atypical antipsychotics; antidepressant monotherapy is contraindicated due to the risk of precipitating mania.
Question 3271Question →

An 8080-year-old man with a history of moderate Alzheimer disease and benign prostatic hyperplasia is brought to the emergency department by his daughter, who is his legally appointed healthcare proxy. Over the past 4848 hours, he has become acutely agitated, disoriented, and has been grasping at invisible objects. Two days ago, he started taking an over-the-counter diphenhydramine preparation for insomnia. The patient's visiting son arrived today and insists the patient be transferred immediately to a psychiatric facility. A recent outpatient urine culture grew >105 CFU/mL>10^5 \text{ CFU/mL} of Escherichia coli sensitive to nitrofurantoin and cephalexin. Recent thyroid tests showed a serum thyroid-stimulating hormone of 1.5 μU/mL1.5 \ \mu\text{U/mL} (normal: 0.4−4.0 μU/mL0.4-4.0 \ \mu\text{U/mL}) and a free thyroxine of 0.5 ng/dL0.5 \text{ ng/dL} (normal: 0.9−2.4 ng/dL0.9-2.4 \text{ ng/dL}). Vital signs show a temperature of 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure 135/85 mm Hg135/85 \text{ mm Hg}, pulse 108/min108\text{/min}, and respirations 16/min16\text{/min}. Physical examination reveals dry oral mucosa, flushed skin, and a palpably distended bladder. Which of the following is the most appropriate initial management for this patient?

Show answer & explanation

Answer: Insertion of a urethral catheter and discontinuation of the sleep aid

Answer

The most appropriate initial management is the insertion of a urethral catheter and discontinuation of the sleep aid.
The patient is experiencing acute delirium secondary to anticholinergic toxicity, directly precipitated by the recent use of over-the-counter diphenhydramine. Patients with pre-existing neurocognitive disorders, such as Alzheimer disease, have diminished cognitive reserves and are exquisitely sensitive to the central effects of anticholinergic medications. The patient's clinical picture is a textbook presentation of the anticholinergic toxidrome, which includes altered mental status and hallucinations ('mad as a hatter'), dry mucous membranes ('dry as a bone'), cutaneous vasodilation ('red as a beet'), tachycardia, and urinary retention ('full as a flask'). The urinary retention is further exacerbated by his underlying benign prostatic hyperplasia. The most appropriate initial management is to physically address the acute urinary retention via bladder catheterization and to immediately discontinue the offending pharmacological agent.

Step-by-Step Solution

1
Analyze the acute clinical presentation.
The patient exhibits acute agitation, visual hallucinations, tachycardia, dry mucosa, flushed skin, and a distended bladder developing over 48 hours.
Identifying the symptom cluster is required to recognize a specific toxicological or medical syndrome.
2
Correlate symptoms with the recent history.
The symptoms align perfectly with anticholinergic toxicity ('mad as a hatter, dry as a bone, red as a beet, full as a flask') triggered by the initiation of over-the-counter diphenhydramine.
Elderly patients with underlying neurocognitive disorders like Alzheimer disease are highly susceptible to the side effects of anticholinergic medications.
3
Determine the most immediate medical intervention required.
The palpable bladder indicates acute urinary retention, exacerbated by benign prostatic hyperplasia and the anticholinergic load. This must be relieved immediately.
Acute urinary retention causes severe agitation in cognitively impaired patients and can lead to renal injury if left untreated.
4
Evaluate and rule out the distracting information.
The psychiatric symptoms are secondary to delirium, not primary psychosis. The UTI is known to be sensitive to narrow-spectrum agents. The thyroid labs indicate central (secondary) hypothyroidism. The son has no legal authority over the appointed proxy.
Ensures the chosen management directly addresses the acute, life-threatening issue without committing clinical or ethical errors.

Key Concept

Diagnosis and management of delirium superimposed on a major neurocognitive disorder due to anticholinergic toxicity and acute urinary retention.
Question 3272Question →

Match each clinical presentation of acute substance intoxication to the primary molecular mechanism of the offending agent.

Click a left item, then click its matching right item

Items

Euphoria, mydriasis, and ischemic chest pain in a young adult.
Severe tooth decay, skin excoriations, and prolonged psychosis.
Visual hallucinations, synesthesia, and intact reality testing.
Extreme psychomotor agitation, multidirectional nystagmus, and reduced pain perception.
Acute severe psychosis, tachycardia, and seizures after smoking an unregulated 'herbal' mixture.

Matches

Show answer & explanation

Answer

Cocaine to reuptake inhibition; Methamphetamine to vesicular displacement; LSD to 5-HT2A agonism; PCP to NMDA antagonism; Synthetic cannabinoids to CB1/CB2 full agonism.
Each clinical presentation perfectly matches the unique mechanism of action of the offending drug. Recognizing the specific toxidrome allows for the identification of the substance and its corresponding molecular mechanism.

Step-by-Step Solution

1
Analyze each clinical presentation to identify the specific substance involved.
Identified cocaine, methamphetamine, LSD, PCP, and synthetic cannabinoids.
Accurate recognition of toxidromes is required before determining the underlying pharmacologic mechanism.
2
Determine the molecular mechanism of action for each identified substance.
Cocaine inhibits reuptake; amphetamines displace vesicles; LSD is a 5-HT2A agonist; PCP is an NMDA antagonist; synthetic cannabinoids are full CB1/CB2 agonists.
USMLE Step 2 frequently requires linking clinical presentations directly to pathophysiological or pharmacological mechanisms.
3
Match the clinical presentation to the corresponding mechanism.
All items are successfully paired.
Finalizing the matches based on pharmacological profiles.

Key Concept

Substance Intoxication Toxidromes and Molecular Mechanisms
Question 3273Question →

Match each patient's clinical presentation with the most appropriate tailored pharmacotherapy or neuromodulation therapy.

Click a left item, then click its matching right item

Items

A 28-year-old woman, 3 weeks postpartum, presenting with mutism, refusal to eat or drink, and delusions that her internal organs are rotting.
A 65-year-old man, 4 weeks post-myocardial infarction, with pervasive low mood and anhedonia; recent ECG shows a QTc interval of 470 ms.
A 34-year-old woman with major depressive disorder on a maximum dose of venlafaxine, reporting resolved tearfulness but persistent profound fatigue, hypersomnia, and a 5-kg (11-lb) weight gain.
A 42-year-old man with a major depressive episode characterized by prominent early morning awakenings, severe anorexia with a 6-kg (13-lb) weight loss, and marked agitation.
A 24-year-old man presenting with severe low mood and psychomotor retardation; history reveals a distinct 5-day period last year of decreased need for sleep, pressured speech, and grandiose spending sprees.

Matches

Show answer & explanation

Answer

Clinical profiles are matched to specific treatments based on symptom clusters (e.g., mirtazapine for insomnia/anorexia, bupropion for fatigue/weight gain), medical comorbidities (sertraline for post-MI with prolonged QTc), acuity (ECT for life-threatening psychosis/inanition), and underlying diagnosis (quetiapine for bipolar depression).
Each correct match optimizes the therapeutic index by utilizing the specific side effect profile or mechanism of action of a psychiatric intervention to address the patient's unique comorbidities and symptom presentation.

Step-by-Step Solution

1
Identify the primary clinical challenge for each patient.
Patient 1: Psychosis/inanition. Patient 2: Cardiac risk. Patient 3: Residual atypical symptoms. Patient 4: Insomnia/anorexia. Patient 5: Bipolar II depression.
Depression management must be tailored to specific symptom profiles and medical histories, rather than using a single algorithm.
2
Select the treatment with a mechanism or side-effect profile that directly addresses the challenge.
ECT for rapid response; Sertraline for cardiac safety; Bupropion for activation; Mirtazapine for sedation/appetite; Quetiapine for bipolar depression.
Aligning treatment properties with patient needs maximizes efficacy and minimizes harm.

Key Concept

Tailored pharmacotherapy and neuromodulation in depressive disorders based on side effect profiles, medical comorbidities, and diagnostic history.
Question 3274Question →

Match the following brief clinical presentations to their most appropriate DSM-5 psychiatric diagnosis.

Click a left item, then click its matching right item

Items

A 26-year-old man avoids public transportation and shopping malls due to a terrifying fear of being unable to easily escape or get help if he develops incapacitating anxiety symptoms.
A 23-year-old woman frequently declines invitations to dinner parties and avoids speaking in meetings due to an overwhelming fear of being judged negatively by her peers.
A 31-year-old man presents with recurrent, sudden episodes of palpitations and a feeling of impending doom, leading to constant worry about experiencing another episode.
A 38-year-old woman reports feeling constantly 'on edge' for the past 8 months, uncontrollably worrying about her children, job, and finances, accompanied by chronic muscle tension.
A 29-year-old veteran experiences recurrent distressing nightmares, avoids fireworks, and feels emotionally detached from his family for the past year.

Matches

Show answer & explanation

Answer

The correct matches align each patient's core clinical fear and timeline with the definitive DSM-5 criteria: Patient 1 matches Agoraphobia, Patient 2 matches Social Anxiety Disorder, Patient 3 matches Panic Disorder, Patient 4 matches Generalized Anxiety Disorder, and Patient 5 matches Posttraumatic Stress Disorder.
Each diagnosis in the DSM-5 is defined by a specific core fear and symptom timeline. Agoraphobia focuses on escape and access to help; Social Anxiety focuses on interpersonal scrutiny; Panic Disorder focuses on the fear of the panic attacks themselves; Generalized Anxiety focuses on pervasive daily worry; and Posttraumatic Stress Disorder focuses on a constellation of intrusion, avoidance, and arousal symptoms following a traumatic event.

Step-by-Step Solution

1
Analyze the clinical presentation of the 26-year-old man avoiding public transport and malls.
Matches Agoraphobia.
The core fear is being unable to easily escape or obtain help in the event of developing panic-like symptoms, which is the defining feature of Agoraphobia.
2
Analyze the clinical presentation of the 23-year-old woman avoiding parties and meetings.
Matches Social Anxiety Disorder.
Her avoidance is driven by a fear of negative evaluation and scrutiny by peers, which defines Social Anxiety Disorder.
3
Analyze the clinical presentation of the 31-year-old man with sudden palpitations and worry about future episodes.
Matches Panic Disorder.
The presence of recurrent unexpected panic attacks followed by anticipatory anxiety (worry about the next attack) is the criteria for Panic Disorder.
4
Analyze the clinical presentation of the 38-year-old woman with chronic worry and muscle tension.
Matches Generalized Anxiety Disorder.
Excessive worry across multiple domains lasting more than 6 months, combined with somatic symptoms like muscle tension, is the classic presentation of Generalized Anxiety Disorder.
5
Analyze the clinical presentation of the 29-year-old veteran with nightmares and emotional detachment.
Matches Posttraumatic Stress Disorder.
The symptoms of re-experiencing (nightmares), avoidance (fireworks), and negative mood alterations (detachment) lasting longer than 1 month following trauma exposure indicate Posttraumatic Stress Disorder.

Key Concept

Differentiating anxiety and trauma-related disorders requires identifying the patient's primary underlying fear, the specific trigger for the anxiety, and the duration of the symptoms.
Question 3275Question →

Match each clinical vignette with the most likely underlying neurocognitive diagnosis.

Click a left item, then click its matching right item

Items

A 73-year-old woman experiences an insidious, progressive decline in her short-term memory over three years, initially struggling to recall recent conversations, with no focal motor deficits on examination.
A 59-year-old woman exhibits socially inappropriate behavior, profound apathy, and diminished hygiene over the past year, while her performance on spatial and memory tasks remains relatively intact.
A 68-year-old man presents with well-formed visual hallucinations of children playing in his room, fluctuating periods of confusion, and resting tremor with rigidity in his upper extremities.
A 76-year-old man has a history of multiple transient ischemic attacks and now presents with a stepwise deterioration in executive functioning and asymmetric deep tendon reflexes.
A 78-year-old man develops a slow, wide-based, shuffling gait, new-onset urinary incontinence, and slowed mentation without prominent cortical signs.

Matches

Show answer & explanation

Answer

The correct matches align each clinical vignette with its signature presentation: the patient with insidious memory loss has Alzheimer disease, the patient with behavioral changes has frontotemporal dementia, the patient with hallucinations and parkinsonism has Lewy body dementia, the patient with stepwise decline has vascular dementia, and the patient with gait impairment and incontinence has normal pressure hydrocephalus.
Each neurocognitive disorder has a distinct clinical signature. Alzheimer disease classically presents with insidious, progressive memory loss. Frontotemporal dementia features early behavioral and personality changes. Lewy body dementia is characterized by recurrent visual hallucinations, fluctuating alertness, and parkinsonism. Vascular dementia follows a stepwise decline temporally related to cerebrovascular events, often with focal neurologic deficits. Normal pressure hydrocephalus presents with the characteristic triad of magnetic gait, incontinence, and cognitive slowing.

Step-by-Step Solution

1
Analyze the clinical vignette for the 73-year-old woman.
Identified insidious short-term memory loss without focal signs.
To differentiate the most common cause of dementia, Alzheimer disease, from other etiologies.
2
Evaluate the 59-year-old woman's symptoms.
Noted early behavioral changes and apathy with spared memory.
These are hallmark features of frontotemporal dementia, distinguishing it from memory-first presentations.
3
Examine the 68-year-old man's presentation.
Recognized visual hallucinations, fluctuating cognition, and parkinsonism.
These form the core clinical criteria for Lewy body dementia.
4
Assess the 76-year-old man's history and exam.
Identified stepwise decline and asymmetric reflexes.
Indicative of multiple cerebral infarctions leading to vascular dementia.
5
Review the 78-year-old man's symptoms.
Found the triad of abnormal gait, incontinence, and cognitive slowing.
This triad is characteristic of normal pressure hydrocephalus, a potentially reversible cause of cognitive impairment.

Key Concept

Differential Diagnosis of Major Neurocognitive Disorders
Estimated Time:2m 0s
Question 3276Question →

A 24-year-old woman is admitted to the inpatient medical-surgical ward for intravenous antibiotic treatment of a complicated lower extremity cellulitis. Over the past 48 hours, her behavior has become increasingly disruptive. During morning rounds, she tells the daytime attending physician, "You are the only brilliant doctor in this hospital. The night shift nurses and doctors are completely incompetent, and I think they are trying to ruin my recovery on purpose." She is pleasant and cooperative with the daytime medical team. However, later that evening, the night charge nurse reports that the patient was screaming at the staff, calling the daytime doctors "clueless," and demanding that the night team ignore the morning care plan. The patient has a history of multiple brief, intense relationships and recurrent suicidal gestures, though she currently denies suicidal ideation. This situation has caused significant arguments between the day and night shift staff regarding her care. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Schedule a joint meeting with all involved medical and nursing staff to establish a unified and consistent care plan

Answer

The most appropriate management strategy is to schedule a joint meeting with all involved medical and nursing staff to establish a unified and consistent care plan.
The patient is exhibiting "splitting," a primitive defense mechanism classically associated with borderline personality disorder (BPD). Splitting involves perceiving individuals or groups as either "all good" (idealized) or "all bad" (devalued). In the inpatient setting, this frequently leads to severe staff conflict, as providers unknowingly take sides. The most effective management strategy is to hold regular, joint team meetings. This ensures clear communication among the staff, prevents the patient from dividing the healthcare team, and establishes firm, consistent boundaries for the patient's care.

Step-by-Step Solution

1
Identify the patient's primary defense mechanism and underlying psychiatric presentation based on the clinical vignette.
The patient alternates between idealizing the day staff and devaluing the night staff (and vice versa), while exhibiting a history of intense relationships and suicidal gestures. This is classic 'splitting' seen in borderline personality disorder (BPD).
Recognizing splitting is essential to understanding why the healthcare team is currently in conflict.
2
Determine the optimal management strategy for a hospitalized patient exhibiting splitting.
The best approach is to prevent the patient from successfully dividing the team. This requires joint communication, strict adherence to a unified care plan, and consistent boundary setting by all staff members.
Unified team meetings address the systemic issue, ensuring that no single provider is isolated (either as a 'savior' or a 'villain') and providing consistent, professional care.

Key Concept

Management of Splitting in Borderline Personality Disorder
Estimated Time:1m 30s
Question 3277Question →

Match each highly specific clinical presentation and diagnostic finding to the most likely corresponding substance-related etiology.

Click a left item, then click its matching right item

Items

Prolonged extreme agitation lasting multiple days, severe autonomic hyperactivity (tachycardia, diaphoresis), and psychotic symptoms; routine urine drug screen is negative.
Acute onset of violent behavior, a dissociative state with diminished pain perception, prominent hypersalivation, muscle rigidity, and rotary nystagmus.
Erythematous perioral dermatitis, progressive muscle weakness, hyporeflexia, and laboratory findings of a normal anion gap metabolic acidosis with profound hypokalemia.
Acute onset of severe delirium, autonomic instability, and generalized tonic-clonic seizures occurring 12 to 24 hours after hospital admission in a patient who uses a 'club drug' for bodybuilding; the patient strictly denies alcohol use.

Matches

Show answer & explanation

Answer

Prolonged agitation with negative urine screen matches Synthetic cathinone intoxication. Violent behavior with rotary nystagmus matches Phencyclidine (PCP) intoxication. Perioral rash with normal anion gap metabolic acidosis matches Toluene (inhalant) toxicity. Acute delirium and seizures in a bodybuilder denying alcohol matches Gamma-hydroxybutyrate (GHB) withdrawal.
Each matching pair relies on distinguishing pathophysiological markers. Synthetic cathinones differentiate themselves via prolonged half-lives and negative UDS. PCP is uniquely characterized by rotary nystagmus and NMDA-mediated dissociative anesthesia. Toluene produces a distinct Type 1 RTA and localized contact dermatitis. GHB withdrawal, acting on GABA-B receptors, produces severe autonomic instability and seizures resembling delirium tremens, often seen in bodybuilders or club-goers.

Step-by-Step Solution

1
Analyze the duration and screening results for the first presentation.
Identifies that a prolonged amphetamine-like psychosis lasting several days with a negative urine drug screen is highly characteristic of synthetic cathinones.
Duration of action is a critical differentiator; cocaine lasts hours, while bath salts last days and evade standard assays.
2
Evaluate the neurologic and ophthalmologic signs in the second presentation.
Identifies rotary nystagmus and dissociative anesthesia as pathognomonic for PCP.
While many drugs cause agitation, the combination of diminished pain perception and rotary nystagmus isolates PCP from other stimulants or hallucinogens.
3
Assess the dermatologic and acid-base disturbances in the third presentation.
Connects perioral dermatitis to inhalant use and the specific metabolic derangement to toluene-induced Type 1 renal tubular acidosis.
Recognizing the mechanism of toluene toxicity explains the non-anion gap metabolic acidosis and resultant hypokalemic weakness.
4
Analyze the withdrawal timeline and patient demographic in the final presentation.
Differentiates from alcohol withdrawal due to the patient demographic (bodybuilder using a 'club drug') and identifies GHB withdrawal.
GHB operates on GABA receptors, and abrupt cessation causes a rapid-onset, severe hyperadrenergic withdrawal state mimicking delirium tremens.

Key Concept

Differentiating complex substance intoxication and withdrawal syndromes requires recognizing highly specific pathophysiologic signatures: synthetic cathinones (prolonged duration), PCP (rotary nystagmus), toluene (Type 1 RTA and hypokalemia), and GHB (GABA-mediated withdrawal mimicking severe alcohol withdrawal).
Question 3278Question →

A 32-year-old female high school teacher presents to the clinic reporting a 4-week history of severely depressed mood, profound fatigue, and sleeping up to 14 hours a day. She says she can no longer concentrate on grading her students' assignments and feels completely worthless. The patient mentions she had a similar period of depression in her mid-twenties. When asked about periods of unusually elevated mood, she recalls an episode three years ago that lasted for 12 days. During that time, she felt "invincible," slept only 2 hours a night without feeling tired, spoke so rapidly that friends could not understand her, and impulsively spent her life savings on a high-risk investment. Her vital signs are within normal limits. Physical examination is unremarkable. Laboratory tests reveal a thyroid-stimulating hormone (TSH) level of 2.1 µU/mL (normal: 0.4-4.0 µU/mL) and free thyroxine (T4) of 1.2 ng/dL (normal: 0.8-1.8 ng/dL). Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiate lithium therapy

Answer

Initiate lithium therapy
The patient is currently experiencing a major depressive episode but has a clear history of a manic episode (elevated mood, decreased need for sleep, rapid speech, and impulsive spending lasting for 12 days). This presentation is diagnostic of bipolar I disorder. The first-line treatment for an acute depressive episode in bipolar disorder includes mood stabilizers, such as lithium or lamotrigine, or certain atypical antipsychotics. Initiating a mood stabilizer appropriately treats the depression while protecting the patient against a manic switch.

Step-by-Step Solution

1
Analyze the patient's current symptoms.
The patient presents with severe sadness, fatigue, feelings of worthlessness, and hypersomnia lasting 4 weeks, indicating a major depressive episode.
To establish the current clinical state requiring treatment.
2
Evaluate the patient's psychiatric history for past mood episodes.
The patient has a history of a 12-day episode characterized by a decreased need for sleep, rapid speech, grandiosity, and impulsive spending.
To differentiate between unipolar major depressive disorder and bipolar disorder.
3
Synthesize the findings to establish a diagnosis.
The history of a full manic episode (lasting at least 7 days with significant impairment) confirms a diagnosis of bipolar I disorder, currently in a depressed episode.
Accurate diagnosis dictates the pharmacological approach and helps avoid dangerous medication errors.
4
Determine the appropriate pharmacotherapy.
A mood stabilizer (e.g., lithium, lamotrigine) or an approved atypical antipsychotic is indicated, whereas antidepressant monotherapy must be avoided.
To effectively treat the depressive episode without precipitating a manic switch.

Key Concept

Diagnosis of bipolar I disorder and the avoidance of antidepressant monotherapy.
Question 3279Question →

Match each patient presentation with the most appropriate next step in clinical management.

Click a left item, then click its matching right item

Items

A 23-year-old female patient discovers a new, firm, mobile lump in her right breast during a routine self-examination.
A 48-year-old female presents with a hard, immobile 3-cm mass in the upper outer quadrant of her left breast, accompanied by subtle skin dimpling.
A 27-year-old postpartum patient reports left-sided breast pain, chills, and fever. Examination reveals a wedge-shaped area of erythema and induration without fluctuance.
A 31-year-old breastfeeding mother with a recent history of mastitis presents with worsening focal pain and a distinct, tender, fluctuant mass in her right breast.

Matches

Show answer & explanation

Answer

The 23-year-old patient requires a targeted ultrasound. The 48-year-old patient requires a diagnostic mammogram and targeted ultrasound. The 27-year-old patient with non-fluctuant erythema requires oral antibiotics and breast emptying. The 31-year-old patient with a fluctuant mass requires ultrasound-guided needle aspiration.
Clinical management of breast symptoms relies heavily on patient demographics and specific exam findings. The choice of initial imaging for a palpable mass is strictly dictated by the age cutoff of 30 years. For lactational infections, the presence of a fluctuant mass changes the management from medical therapy alone (antibiotics and drainage through feeding) to requiring procedural intervention (aspiration).

Step-by-Step Solution

1
Evaluate the patient's age to determine the correct imaging pathway for a new palpable breast mass.
Patients under 30 years old should undergo ultrasound primarily, whereas patients 30 years and older should undergo both mammography and ultrasound.
Age is the primary determinant for breast imaging modality due to changes in breast tissue density over time.
2
Differentiate between uncomplicated lactational mastitis and a lactational breast abscess based on physical exam findings.
The presence of induration and erythema alone points to mastitis, treated with antibiotics and continued feeding. The presence of fluctuance points to an abscess, requiring physical drainage.
Antibiotics alone cannot adequately penetrate and resolve a walled-off fluid collection (abscess).

Key Concept

Age-based imaging guidelines for palpable breast masses and the clinical differentiation between lactational mastitis and breast abscess.
Question 3280Question →

A 24-year-old woman with a 3-year history of schizophrenia is admitted to the inpatient psychiatric unit. For the past four days, she has been entirely mute, refuses all food and fluids, and maintains rigid postures for hours. When the examiner attempts to reposition her arm, it remains exactly where placed. Her current medication is oral risperidone 4 mg daily, which her parents state she took consistently until three days ago. Her vital signs are within normal limits. Arrange the following management steps in the most appropriate chronological sequence for this patient's episode of care, assuming sequential escalation is required due to refractory symptoms before eventual resolution.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first discontinue risperidone, then administer an IV lorazepam test dose, followed by scheduled high-dose lorazepam, then proceed to ECT for refractory symptoms, and finally restart a low-D2 affinity antipsychotic once catatonia has resolved.
The correct algorithm for managing catatonia begins with the immediate cessation of dopamine antagonists to prevent worsening or NMS. Once stopped, an IV lorazepam challenge confirms the diagnosis and provides temporary relief. This is followed by scheduled, high-dose benzodiazepine therapy for definitive treatment. If the patient does not respond to scheduled benzodiazepines, ECT is the indicated treatment for refractory catatonia. Finally, only after the catatonia has completely resolved, an atypical antipsychotic with low D2 receptor affinity (such as quetiapine or clozapine) should be cautiously initiated to manage the underlying schizophrenia.

Step-by-Step Solution

1
Recognize the clinical presentation
The patient exhibits mutism, negativism (refusal to eat/drink), and waxy flexibility (arm remains where placed).
These findings are classic for catatonia, a neuropsychiatric syndrome that can occur in the context of schizophrenia or mood disorders.
2
Determine the immediate first step in management
Discontinue the offending agent, risperidone.
Continuing dopamine antagonists during acute catatonia can worsen the condition and increase the risk of progression to life-threatening neuroleptic malignant syndrome (NMS).
3
Select the initial diagnostic and therapeutic intervention
Perform a lorazepam challenge test.
Intravenous lorazepam rapidly confirms the diagnosis if the patient's catatonic signs temporarily improve.
4
Identify the definitive first-line pharmacological treatment
Start scheduled, high-dose lorazepam.
Because the challenge test only provides transient relief, a scheduled regimen is needed to achieve sustained remission of catatonic symptoms.
5
Establish the next step for treatment-refractory symptoms
Proceed to electroconvulsive therapy (ECT).
When standard pharmacological escalation fails, or if the patient develops autonomic instability, ECT is the most effective and definitive treatment for catatonia.
6
Plan for post-episode maintenance therapy
Restart an antipsychotic with a low D2 receptor affinity profile (e.g., quetiapine, clozapine).
Once catatonia has resolved, the underlying schizophrenia requires treatment. High-potency agents should be avoided to prevent recurrence of catatonia.

Key Concept

The stepwise management of catatonia in schizophrenia involves discontinuing antipsychotics, initiating a lorazepam challenge followed by scheduled benzodiazepines, utilizing ECT for refractory cases, and cautiously restarting low-potency antipsychotics only after full resolution.
PreviousPage 164 / 414Next